STATE HOUSE, BOSTON, DEC. 12, 2019…..State marijuana regulators on Thursday eased their ban on vaping product sales, allowing certain types of products to return to store shelves one day after state public health officials backed off a ban on nicotine vape sales.
As of 2 p.m. Thursday, the Cannabis Control Commission permitted licensed marijuana retailers to sell devices that vaporize marijuana flower for medical marijuana patients and non-medical users, devices that are used to vaporize marijuana concentrate but do not actually contain any marijuana themselves, and vaporizer cartridges that are manufactured beginning Thursday and pass a screening for contaminants like vitamin E acetate.
Still off-limits are any vaping products manufactured before Thursday that contain marijuana, meaning retailers cannot sell any vape cartridges that they have been holding in quarantine.
Marijuana vaping products have been unavailable to consumers since September, when Gov. Charlie Baker imposed a temporary ban on the sale of any vaping product amid a national outbreak of vaping-related lung disease, including three deaths in Massachusetts. When a judge ruled the CCC is the only agency that can regulate marijuana vapes, the CCC put in place an indefinite quarantine of all vaping products.
The prohibition was first imposed to allow public health officials to glean more about what is causing some people who vape to come down with serious lung illnesses. Last month, the U.S. Centers for Disease Control announced that vitamin E acetate, often added as a thickening agent to products that contain THC, had been identified as a possible culprit in the yet-unexplained illnesses and injuries.
In the amended quarantine order the CCC sent to licensees on Thursday, the agency said vitamin E acetate “has been identified as having a scientifically significant correlation with” the lung illnesses “but may not ultimately be the only substance identified as such.”
Before a retailer can resume sales, operators must “confirm the finished products do not contain vitamin E acetate” and remain in compliance with the CCC’s testing protocols, and post a sign in their retail location that reads, “This product has been tested for contaminants, including Vitamin E Acetate, with no adverse findings. WARNING: Vaporizer Products may contain ingredients harmful to health when inhaled.” Vape sales will be required to include an insert with the same language at the point of sale. Any retailer that sells disposable and reusable vaporizer devices must include a written insert identifying the product manufacturer, battery, and other known components, and a disclosure of the materials used in the atomizer coil.
In its announcement Thursday, the CCC said that it will continue to test vaporizer products for the presence of toxicants or contaminants, including vitamin E acetate and heavy metals.
“Using validated tests, Independent Testing Laboratories have not identified detectable levels of vitamin E acetate from 91 initial vaporizer product testing samples that were collected from unique source production batches from 19 licensees in November,” the agency said in its announcement. “The Commission is still awaiting the results of 126 additional vaporizer product test samples collected from unique source production batches from 22 licensees in December.”
The CCC said Thursday that it is still investigating whether any of the samples it collected in December exceed the limits for heavy metals.
Going forward, in accordance with new regulations the CCC approved just before the ban was put in place in September, extract and concentrate manufacturers must include on their products’ lists of ingredients every additive used in the product, including thickening agents and specific terpenes, which are oils that naturally occur in cannabis and contribute to its distinctive odor.
The specific requirement is that marijuana product labeling lists “the amount of any specific additives infused or incorporated during the manufacturing process, including, but not limited to, thickening agents and specific terpenes, expressed in absolute terms and as a percentage of volume.”
Until those regulations went into effect this fall, the CCC’s rules for the marijuana industry only required the ingredient list to include information about the cannabinoid profile of the marijuana and its THC content.
On Wednesday, the Public Health Council rescinded a ban on sales of all nicotine vaping products and approved new regulations to make those vaping products again available in stores, despite acknowledging that they still do not know what is causing lung injuries and illnesses among some people who vape.
“Today’s ‘lifting’ of the quarantine order on cannabis vaping products by the CCC’s Executive Director Shawn Collins is reflective of the thorough, thoughtful, collaborative, and evidence-based approach he has led the CCC through. This approach is also reflective of the benefits and importance of a regulated market — one driven by transparency, regulation, and consumer and patient safety,” David Torrisi, executive director of the Commonwealth Dispensary Association, said Thursday.